Search Results 1841-1850 of 19661 for hemoglobin

  1. Publications - Kevin I. Perry, M.D. - Mayo Clinic

    Prospective Noninvasive Hemoglobin Monitoring in the Outpatient Total Joint Arthroplasty Setting. J Bone Joint Surg Am. 2025 Feb 19; 107 (4):364-371 Epub ...

  2. Mayo Clinic Minute: How low testosterone can affect men's health

    Testosterone levels normally decline as men age but low levels could affect health. Learn more in this Mayo Clinic Minute.

  3. Reishi Mushroom for Fatigue And/or Arthralgias for Patients With Breast Cancer on Aromatase Inhibitors - Mayo Clinic

    Hemoglobin ≥ 10 g/dL;; Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase (ALT) or Aspartate transaminase (AST) ≤ 1.2 x ...

  4. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; INR or PTT/aPTT ≤ 1.5 × ULN unless participant is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range ...

  5. Futibatinib and Pembrolizumab for the Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer - Mayo Clinic

    - Hemoglobin >= 8.0 g/dL (=< 15 days prior to registration) - Platelet count >= 75,000/mm^3 (=< 15 days prior to registration) - Albumin >= 2.5 g/dL (=< 15 ...

  6. A Study to Evaluate the Effectiveness of M7824 Monotherapy in Locally Advanced or Metastatic Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) - Mayo Clinic

    ... hemoglobin (Hgb) ≥ 9 g/dL. Adequate hepatic function defined by a total bilirubin level ≤ 1.5 × upper limit of normal (ULN), an aspartate aminotransferase ...

  7. S1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer - Mayo Clinic

    Hemoglobin >= 9 g/dL obtained within 28 days prior to sub-study registration; Serum bilirubin =< institutional upper limit of normal (IULN) within 28 days ...

  8. Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer - Mayo Clinic

    Hemoglobin (Hgb) ≥ 9 g/dl; Absolute neutrophil count ≥ 1,500/mcL; Platelets ≥ 100,000/mcL; Total bilirubin ≤ 1.5 x normal institutional limits; this will ...

  9. (HARBOR) Study To Evaluate Efficacy And Safety Of BLU-263 Versus Placebo In Patients With Indolent Systemic Mastocytosis - Mayo Clinic

    Hemoglobin < 10 g/dL;; Platelet count < 100,000/µL. Hepatomegaly with ascites and impaired liver function;; Palpable splenomegaly with hypersplenism ...

  10. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL (obtained ≤ 15 days prior to registration). Absolute neutrophil count (ANC) ≥ 1500/mm^3 (obtained ≤ 15 days prior to registration) ...